Costs Attributable to Clostridioides difficile Infection Based on the Setting of Onset
Clinical Infectious Diseases · 2023
DOI: 10.1093/cid/ciac841 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2023. Verfasst von John M Sahrmann und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri, USA. Hauptthemen laut MEDLINE: Cross Infection, Clostridioides difficile, Clostridium Infections. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, Washington University Center for Administrative Data Research, National Center for Advancing Translational Sciences.
Abstract (Originalsprache)
Background
Although hospital-onset Clostridioides difficile infection (CDI) is associated with significant healthcare costs, the economic burden of CDI with onset in other facilities or the community has not been well studied.
Methods
Incident CDI cases were identified using 2011–2017 Medicare fee-for-service data. Controls were randomly selected in a 4:1 ratio matching to the CDI case surveillance definition. Inverse probability of exposure weights were used to balance on measured confounders. One-, 3-, and 5-year cumulative costs attributable to CDI were computed using a 3-part estimator (parametric survival model and pair of 2-part models predicting costs separately in intervals where death did and did not occur).
Results
A total of 60 492 CDI cases were frequency-matched to 241 968 controls. One-, 3-, and 5-year adjusted attributable costs were highest for hospital-onset CDI at $14 257, $18 953, and $21 792, respectively, compared with hospitalized controls and lowest for community-associated CDI compared with community controls at $1013, $3161, and $6454, respectively. Adjusted 1-, 3-, and 5-year costs attributable to community-onset healthcare facility–associated CDI were $8222, $13 066, and $16 329 and for other healthcare facility-onset CDI were $5345, $6764, and $7125, respectively.
Conclusions
Economic costs attributable to CDI in elderly persons were highest for hospital-onset and community-onset healthcare facility–associated CDI. Although lower, attributable costs due to CDI were significantly higher in cases with CDI onset in the community or other healthcare facility than for comparable persons without CDI. Additional strategies to prevent CDI in the elderly are needed to reduce morbidity and healthcare expenditures.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri, USA.
- Division of Public Health Sciences, Washington University School of Medicine, St. Louis, Missouri, USA.
- Pfizer, Inc., Collegeville, Pennsylvania, USA.
Förderung
- NCATS NIH HHS
- Washington University Center for Administrative Data Research
- National Center for Advancing Translational Sciences
- National Institutes of Health
Zitieren
APA
Sahrmann, J. M., Olsen, M. A., Stwalley, D., Yu, H., & Dubberke, E. R. (2023). Costs Attributable to Clostridioides difficile Infection Based on the Setting of Onset. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciac841
Vancouver
Sahrmann JM, Olsen MA, Stwalley D, Yu H, Dubberke ER. Costs Attributable to Clostridioides difficile Infection Based on the Setting of Onset. Clinical Infectious Diseases. 2023. doi:10.1093/cid/ciac841
BibTeX
@article{Sahrmann2023,
author = {Sahrmann, John M and Olsen, Margaret A and Stwalley, Dustin and Yu, Holly and Dubberke, Erik R},
title = {Costs Attributable to Clostridioides difficile Infection Based on the Setting of Onset},
journal = {Clinical Infectious Diseases},
year = {2023},
doi = {10.1093/cid/ciac841}
}
EUVIMED